Endoscopic Treatment with Band Ligation and Electrocoagulation for Non-Variceal, Non-Ulcer Upper Gastrointestinal Bleeding.
- Author:
Hwa Min KIM
1
;
Yang Suh KU
;
Moon Gi CHUNG
;
Young Nam KIM
;
Do Yoon LIM
;
Kwang An KWON
;
Dong Kyun PARK
;
Sun Suk KIM
;
Yeon Suk KIM
;
So Young KWON
;
Yu Kyung KIM
;
Duck Joo CHOI
;
Ju Hyun KIM
Author Information
1. Department of Internal Medicine, Gachon Medical School, Gil Medical Center, Incheon, Korea. yskoo@gilhospital.com
- Publication Type:Original Article
- Keywords:
Gastrointestinal bleeding;
Endoscopic band ligation;
Electrocoagulation
- MeSH:
Risk Factors
- From:Korean Journal of Gastrointestinal Endoscopy
2006;33(2):69-76
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: This study compared the therapeutic efficacy of endoscopic band ligation (EBL) with that of electrocoagulation for treating non-variceal, non-ulcer (NVNU) upper gastrointestinal (UGI) bleeding. METHODS: This study included 89 patients who underwent EBL and 56 patients in whom monopolar electrocoagulation was performed for NVNU UGI bleeding. The lesions treated were Mallory-Weiss tear in 91 patients, Dieulafoy's lesion in 42 patients and angiodysplasia in 12 patients. RESULTS: The initial hemostatic rate was 97% in the EBL group and 91% in the electrocoagulation group, but this was not statistically different. Rebleeding occurred in 5 of 89 patients (5.6%) in the EBL group and in 8 of 56 patients (14.3%) in the electrocoagulation group (p=0.07). Thrombocytopenia or prothrombin time prolongation was confirmed to be a significant risk factor for rebleeding. The rebleeding rate in the high risk group was significantly lower than in the EBL group (9% vs. 30%, respectively, p=0.03). The median procedure time was significantly shorter in the EBL group compared with that in the electrocoagulation group (median 5.6 minutes vs. 8.3 minutes, respectively, p=0.04). CONCLUSIONS: EBL and electrocoagulation are both effective for treating NVNU UGI bleeding, and EBL is especially safe and effective for the cases with a high risk for rebleeding.
